Active Ingredient History

NOW
  • Now
Cisatracurium is a cis-cis isomer of atracurium and five time as potent as atracurium. The drug is approved by FDA and marketed under the name Nimbex. It is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation due to its antagonistic properties toward nicotinic acetylcholine receptors.   NCATS

  • SMILES: COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(C)CCc5cc(OC)c(OC)cc5[C@H]4Cc6ccc(OC)c(OC)c6)cc1OC
  • InChIKey: YXSLJKQTIDHPOT-LJCJQEJUSA-N
  • Mol. Mass: 929.16
  • ALogP: 8.07
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$4.0200 - $142.3020
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(1r,1'r,2r,2'r)-atracurium besylate | (1r-cis,1'r-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate | (1r-cis,1'r-cis)-atracurium besylate | 51w89 | 51 w89 | besilate de cisatracurium | besilato de cisatracurio | cisastracurium | cisastracurium besylate | cisatracurii besilas | cisatracurium | cis-atracurium | cisatracurium besilate | cisatracurium besylate | cisatracurium dibenzenesulfonate | cisatracurium-kation | nimbex

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue